Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:PIII On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumePIIIP3 Health Partners$10.53+2.3%$9.79$1.52▼$16.89$74.55M1.6239,888 shs30,701 shsThe 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformancePIIIP3 Health Partners+2.33%-2.50%-9.07%+282.91%+64.53%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumePIIIP3 Health Partners$10.53+2.3%$9.79$1.52▼$16.89$74.55M1.6239,888 shs30,701 shsThe 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformancePIIIP3 Health Partners+2.33%-2.50%-9.07%+282.91%+64.53%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PricePIIIP3 Health Partners 2.00Hold$14.0032.95% UpsideCurrent Analyst Ratings BreakdownLatest PIII Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/28/2026PIIIP3 Health Partners Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)5/22/2026PIIIP3 Health Partners TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold$3.00 ➝ $14.005/15/2026PIIIP3 Health Partners UBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$14.005/15/2026PIIIP3 Health Partners Lake Street CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$4.00 ➝ $14.004/21/2026PIIIP3 Health Partners Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)(Data available from 7/8/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookPIIIP3 Health Partners$1.46B0.05N/AN/A($21.55) per share-0.49Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DatePIIIP3 Health Partners-$147.95M-$38.60N/AN/AN/A-8.57%N/A-19.99%8/13/2026 (Estimated)Latest PIII EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2026Q1 2026PIIIP3 Health Partners-$4.85$0.32+$5.17$0.32$391.45 million$386.39 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthPIIIP3 Health PartnersN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioPIIIP3 Health PartnersN/A0.330.33Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipPIIIP3 Health Partners7.75%Insider OwnershipCompanyInsider OwnershipPIIIP3 Health Partners10.86%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionablePIIIP3 Health Partners5007.24 million6.46 millionNot OptionablePIII HeadlinesRecent News About These CompaniesP3 Health Partners (NASDAQ:PIII) Raised to Hold at Wall Street ZenJuly 4, 2026 | americanbankingnews.comP3 Health Partners (PIII) Stock Sees Fair Value Lift After Strong EBITDA And GuidanceJune 27, 2026 | finance.yahoo.comPIII Share News TodayJune 22, 2026 | uk.investing.comP3 Health Partners Stockholders Back Board, Warrants ProposalJune 10, 2026 | tipranks.comP3 Health Partners Regains Full Nasdaq Listing ComplianceMay 26, 2026 | tipranks.comWhat's going on with P3 Health Partners stock Monday?May 18, 2026 | msn.comTrump Rattled Markets Again and These 3 Forgotten Stocks Under $30 Were the Unlikely WinnersMay 18, 2026 | 247wallst.comP3 Health Partners Signals Turnaround In Earnings CallMay 15, 2026 | tipranks.comP3 Health Partners Executes Debt Exchange to Bolster EquityMay 15, 2026 | tipranks.comP3 Health Partners (PIII) stock surges over 42% after hours: Here's whyMay 15, 2026 | msn.comP3 Health Partners Inc (PIII) Q1 2026 Earnings Call Highlights: Surpassing Expectations and ...May 15, 2026 | finance.yahoo.comP3 Health Partners (PIII) Stock Surges Over 42% After Hours: Here's WhyMay 15, 2026 | benzinga.comWhat To Expect From P3 Health Partners Inc (PIII) Q1 2026 EarningsMay 14, 2026 | finance.yahoo.comP3 Health Partners (PIII) price target decreased by 12.50% to 3.57April 28, 2026 | msn.comP3 Health Partners Schedules First Quarter 2026 Earnings Release and Conference CallApril 16, 2026 | businesswire.comP3 Health Partners Inc. (PIII) Q4 2025 Earnings Call TranscriptMarch 26, 2026 | seekingalpha.comP3 Health Partners Announces Fourth Quarter and Full Year 2025 ResultsMarch 26, 2026 | businesswire.comP3 Health Partners Inc (PIII) Q4 2025: Everything You Need To Know Ahead Of EarningsMarch 25, 2026 | finance.yahoo.comP3 Health Partners Schedules Fourth Quarter and Full Year 2025 Earnings Release and Conference CallMarch 13, 2026 | businesswire.comP3 Health Partners (PIII) price target decreased by 19.23% to 10.71December 6, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimePIII Company DescriptionsP3 Health Partners NASDAQ:PIII$10.53 +0.24 (+2.33%) Closing price 07/7/2026 04:00 PM EasternExtended Trading$10.59 +0.06 (+0.58%) As of 07/7/2026 07:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc. was founded in 2020 and is based in Henderson, Nevada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Apple and Broadcom Forge a Decade-Long Silicon Fortress SK Hynix’s Nasdaq Listing Could Reset the AI Memory Trade The AI Chip Sell-Off Looks Scary, But the Real Story May Be Liquidity Palantir's CEO Just Called Out OpenAI and Anthropic Silicon Starvation: Amazon Feasts on Legacy GPUs GE Vernova’s Power Surge Turns the Grid Into an AI Trade 3 Quiet AI Revenue Accelerators With Sales Growth Outpacing Peers Abivax: Wall Street Catches Up to the Data Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
